How often should rheumatology labwork be rechecked?
One common question I hear from patients is: “Should we recheck my labs?” It’s a fair question—especially if you’re dealing with a chronic condition or not feeling your best. But here’s the truth: more lab testing isn’t always better care.
Labs are a tool. They give us a snapshot in time, not the full story.
Repeating them too frequently can lead to unnecessary anxiety, false alarms, and even interventions that you don’t actually need. I’ve seen patients spiral over minor fluctuations that are completely normal.
Items that are flagged as “red” are not always clinically significant.
So when should we repeat labs?
Many rheumatology medications require routine laboratory monitoring.
If we’ve started a new medication that requires routine monitoring, I typically recheck within a timeframe that matches how that medication works—sometimes weeks, sometimes a few months. If you’re having new or worsening symptoms, that’s another reason to reassess. And for chronic conditions, there are evidence-based intervals that help us monitor safely without overdoing it.
But if you’re feeling well, stable on your treatment, and your previous labs were reassuring, repeating tests too soon often doesn’t change management. In those cases, I’d rather focus on how you’re actually doing—your energy, your function, your quality of life.
There’s also a bigger picture to consider. Every lab we order should have a purpose. I always ask myself: “Will this result change what I do next?” If the answer is no, we pause.
Are there labs in rheumatology that are not typically rechecked?
Not all labs in rheumatology are meant to be followed over time. Some tests are primarily diagnostic—they help us make the diagnosis, but don’t add much value when routinely repeated.
Examples include the antinuclear antibody (ANA), rheumatoid factor (RF), and anti-CCP antibodies.
Once these are established, repeating them usually doesn’t change management and can sometimes create more confusion than clarity.
What are some labs in rheumatology that are routinely rechecked?
The sedimentation rate (ESR) and C-reactive protein (CRP) fall into this category. These are markers of inflammation that can fluctuate—sometimes even week to week—depending on disease activity, infections, stress, or other factors. They can be really useful when trended over time.
Watching the pattern over time is often far more informative than any single value.
I often find it helpful to actually graph these results, both for my own clinical assessment and to help patients visualize their progress.
We routinely monitor the complete blood count (CBC) along with the comprehensive metabolic panel (CMP). The CMP gives us important information about your liver function, kidney function, and electrolytes. Since many medications are processed through the liver and kidneys, keeping an eye on these tests helps us make sure your treatment stays safe and effective.
In patients with inflammatory myositis, such as dermatomyositis or polymyositis, I take a similar approach with creatine kinase (CPK). This muscle enzyme can serve as a useful marker of muscle inflammation. As treatment begins to work, we often see CPK levels trend downward, which can provide reassurance that we’re moving in the right direction—even before patients feel significant clinical improvement.
Checking your labs is about doing what’s necessary, at the right time, for the right reasons. And sometimes, the best decision is to wait.